Healthcare provider profile · identity verified

William Jornlin, MD

Family Practice · ROSEVILLE, CA · NPI 1235112160

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	433	76
Lisinopril	Lisinopril	372	65
Amlodipine Besylate	Amlodipine Besylate	310	53
Metformin Hcl	Metformin Hcl	287	40
Gabapentin	Gabapentin	272	48
Omeprazole	Omeprazole	268	47
Levothyroxine Sodium	Levothyroxine Sodium	254	40
Ozempic	Semaglutide	247	32
Rosuvastatin Calcium	Rosuvastatin Calcium	242	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	239	40
Baclofen	Baclofen	180	48
Chlorthalidone	Chlorthalidone	172	25
Metoprolol Succinate	Metoprolol Succinate	165	26
Tramadol Hcl	Tramadol Hcl	160	24
Tamsulosin Hcl	Tamsulosin Hcl	157	31
Losartan Potassium	Losartan Potassium	153	29
Jardiance	Empagliflozin	142	18
Potassium Chloride	Potassium Chloride	141	22
Famotidine	Famotidine	139	24
Fluticasone Propionate	Fluticasone Propionate	132	51
Trazodone Hcl	Trazodone Hcl	127	27
Ibuprofen	Ibuprofen	123	35
Pioglitazone Hcl	Pioglitazone Hcl	123	19
Albuterol Sulfate Hfa	Albuterol Sulfate	114	40
Metoprolol Tartrate	Metoprolol Tartrate	112	18
Simvastatin	Simvastatin	112	19
Alendronate Sodium	Alendronate Sodium	92	25
Eliquis	Apixaban	82	16
Furosemide	Furosemide	80	14
Valsartan	Valsartan	77	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	16
Hydrochlorothiazide	Hydrochlorothiazide	76	14
Escitalopram Oxalate	Escitalopram Oxalate	75	14
Quetiapine Fumarate	Quetiapine Fumarate	73	20
Finasteride	Finasteride	72	16
Celecoxib	Celecoxib	68	suppressed
Ondansetron Odt	Ondansetron	66	18
Pravastatin Sodium	Pravastatin Sodium	62	12
Naproxen	Naproxen	60	14
Oxybutynin Chloride Er	Oxybutynin Chloride	60	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	59	16
Allopurinol	Allopurinol	58	11
Bupropion Xl	Bupropion Hcl	57	suppressed
Montelukast Sodium	Montelukast Sodium	57	suppressed
Spironolactone	Spironolactone	57	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	55	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	55	suppressed
Ropinirole Hcl	Ropinirole Hcl	55	suppressed
Pregabalin	Pregabalin	53	suppressed
Hydralazine Hcl	Hydralazine Hcl	52	13
Tradjenta	Linagliptin	51	suppressed
Lorazepam	Lorazepam	50	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	49	suppressed
Estradiol	Estradiol	48	11
Meloxicam	Meloxicam	48	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Metformin Hcl Er	Metformin Hcl	42	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Topiramate	Topiramate	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Aripiprazole	Aripiprazole	38	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	37	16
Buprenorphine	Buprenorphine	36	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	35	35
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Incruse Ellipta	Umeclidinium Bromide	34	suppressed
Carvedilol	Carvedilol	33	13
Diclofenac Sodium	Diclofenac Sodium	33	18
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Diazepam	Diazepam	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	17
Olanzapine	Olanzapine	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Lidocaine	Lidocaine	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Myrbetriq	Mirabegron	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Methylprednisolone	Methylprednisolone	20	17
Mounjaro	Tirzepatide	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Glipizide	Glipizide	18	suppressed
Prednisone	Prednisone	18	16
Acyclovir	Acyclovir	17	suppressed
Clonidine	Clonidine	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Colchicine	Colchicine	16	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Sumatriptan	Sumatriptan	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error